Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8883833
SERIAL NO

12275165

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to substituted benzothiazoles, benzoxazoles—and their counterparts having pyridine and pyrimidine rings replacing the benzene ring—that are PDE4 inhibitors useful for treating stroke, myocardial infarct, and cardiovascular inflammatory conditions, to pharmaceutical compositions comprising these compounds, and to methods for the treatment of stroke, myocardial infarct, and cardiovascular inflammatory conditions in a mammal. The compounds have general formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DECODE GENETICS EHF101 REYKJAVIK

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burgin, Alex Kingston, US 30 164
Gurney, Mark E Grand Rapids, US 88 598
Kiselyov, Alexander San Diego, US 29 280
Rao, Munagala Westmont, US 6 11
Sandanayaka, Vincent Northboro, US 26 226
Singh, Jasbir Naperville, US 100 683

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 11, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00